ShareValue scores for TRLS.LSE: Valuation 59, Quality 47, Growth 75, Health 51.
TRLS.LSELSE
Trellus Health plc
£0.12
(0.00%)
TRLS.LSELSE
Trellus Health plc
£0.12(0.00%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Strong
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
8% to 18%
Rating
Trap Risk
Return
8% to 18%
Valuation
59
Fair Value
Price vs Value
Quality
47
Moderate
Business Strength
Growth
75
Strong
Revenue & Earnings
Health
51
Moderate
Financial Stability
Momentum
8
Bearish
Price Trend
Company Details
About
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease, including Crohn's Disease and ulcerative colitis. The company was incorporated in 2020 and is headquartered in White Plains, New York.
Market Cap$23M
P/E RatioN/A
Dividend YieldNone
Sector Rank#271
Score Analysis
AI Investment Thesis
Data as of:Jun 29, 2026
|Last calculated:Jun 29, 2026